Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Am J Surg Pathol. 2017 Aug;41(8):1097–1104. doi: 10.1097/PAS.0000000000000887

Figure 3.

Figure 3

Kaplan-Meier curves for disease-free survival (A) and overall survival (B) in patients with ypT1a or ypT1b, ypT1c and ypT2 pancreatic ductal adenocarcinoma who underwent PD after neoadjuvant therapy using the new AJCC Staging Manual (8th edition). Patients with ypT1a or ypT1b disease have significantly longer disease-free survival and overall survival than those with ypT1c and those with ypT2 disease (p<0.05). However there is no significant difference in either disease-free survival or overall survival between the patients with ypT1c disease and those with ypT2 disease (p>0.05).